234 related articles for article (PubMed ID: 18552173)
21. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression.
Zeng W; Fu K; Quintanilla-Fend L; Lim M; Ondrejka S; Hsi ED
Am J Surg Pathol; 2012 Feb; 36(2):214-9. PubMed ID: 22251940
[TBL] [Abstract][Full Text] [Related]
24. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
[TBL] [Abstract][Full Text] [Related]
25. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
[TBL] [Abstract][Full Text] [Related]
26. Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.
Krsková L; Kalinová M; Brízová H; Mrhalová M; Sumerauer D; Kodet R
Cancer Genet Cytogenet; 2009 Aug; 193(1):1-8. PubMed ID: 19602458
[TBL] [Abstract][Full Text] [Related]
27. Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Hashimoto Y; Nakamura N; Kuze T; Abe M; Wakasa H
Fukushima J Med Sci; 1997 Dec; 43(2):87-98. PubMed ID: 9640844
[TBL] [Abstract][Full Text] [Related]
28. The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241.
Howe D; Lynas C
Haematologica; 2001 Jun; 86(6):563-9. PubMed ID: 11418364
[TBL] [Abstract][Full Text] [Related]
29. The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index.
Slotta-Huspenina J; Koch I; de Leval L; Keller G; Klier M; Bink K; Kremer M; Raffeld M; Fend F; Quintanilla-Martinez L
Haematologica; 2012 Sep; 97(9):1422-30. PubMed ID: 22315488
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia.
Miranda RN; Briggs RC; Kinney MC; Veno PA; Hammer RD; Cousar JB
Mod Pathol; 2000 Dec; 13(12):1308-14. PubMed ID: 11144927
[TBL] [Abstract][Full Text] [Related]
31. Morphologic diagnosis of leukaemic B-lymphoproliferative disorders and the role of cyclin D1 expression.
Oertel J; Kingreen D; Busemann C; Stein H; Dörken B
J Cancer Res Clin Oncol; 2002 Apr; 128(4):182-8. PubMed ID: 11935308
[TBL] [Abstract][Full Text] [Related]
32. Catalyzed signal amplification for cyclin D1 detection in mantle cell lymphoma.
Barranco C; Mate JL; Ariza A; Baró T; Díaz E; Munné A; Serrano S
Mod Pathol; 2003 Feb; 16(2):161-5. PubMed ID: 12591969
[TBL] [Abstract][Full Text] [Related]
33. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue.
Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK
Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades.
Chen Z; Huang X; Ye J; Pan P; Cao Q; Yang B; Li Z; Su M; Huang C; Gu J
Cancer; 2010 Apr; 116(8):1953-63. PubMed ID: 20186824
[TBL] [Abstract][Full Text] [Related]
35. Cyclin alterations in giant cell tumor of bone.
Kauzman A; Li SQ; Bradley G; Bell RS; Wunder JS; Kandel R
Mod Pathol; 2003 Mar; 16(3):210-8. PubMed ID: 12640100
[TBL] [Abstract][Full Text] [Related]
36. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
37. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
38. Significance of cyclin D1 expression in meningiomas: a preliminary study.
Alama A; Barbieri F; Spaziante R; Bruzzo C; Dadati P; Dorcaratto A; Ravetti JL
J Clin Neurosci; 2007 Apr; 14(4):355-8. PubMed ID: 17240151
[TBL] [Abstract][Full Text] [Related]
39. Antibody selection in immunohistochemical detection of cyclin D1 in mantle cell lymphoma.
Torlakovic E; Nielsen S; Vyberg M
Am J Clin Pathol; 2005 Nov; 124(5):782-9. PubMed ID: 16203276
[TBL] [Abstract][Full Text] [Related]
40. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]